Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abliva Ab (NEVPF)

Abliva Ab (NEVPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abliva Ab MEDICON VILLAGE SCHEELEVAGEN LUND V7 22381 SWE

https://abliva.com Employees: 6 P: 46 0 46-275 62 20

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Abliva AB is a clinical-stage biotech company develops medicines for the treatment of primary mitochondrial diseases. Abliva AB, formerly known as NeuroVive Pharmaceutical AB, is based in Lund, Sweden.

Key Statistics

Overview:

Market Capitalization, $K 11,284
Enterprise Value, $K 5,844
Shares Outstanding, K 403,010
Float, K 403,010
% Float 100.00%
Short Volume Ratio 1.00
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 10 K
Annual Net Income, $ -9,010 K
Last Quarter Sales, $ -30 K
Last Quarter Net Income, $ -2,410 K
EBIT, $ -8,760 K
EBITDA, $ -8,590 K

Growth:

1-Year Return 180.00%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 90.91%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 11/29/24
Next Earnings Date 02/28/25
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NEVPF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -117.92%
Return-on-Assets % -102.44%
Profit Margin % -90,100.00%
Debt/Equity 0.00
Price/Sales 188.07
Price/Cash Flow N/A
Price/Book 1.69
Book Value/Share 0.00
Interest Coverage -900.00
60-Month Beta -1.18
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar